{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:59:48Z","timestamp":1791910788326,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The mortality rate of acute ST-segment elevation myocardial infarction (STEMI) remains substantial, despite advances in treatment strategies. Coronary microcirculation dysfunction (CMD) persists after percutaneous coronary intervention (PCI) in a substantial proportion of STEMI patients. The association between CMD assessed using myocardial contrast echocardiography (MCE) and prognosis requires further elucidation. This study aimed to evaluate the impact of CMD after successful PCI on the prognosis of patients with STEMI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We enrolled 167 patients with STEMI after PCI who underwent MCE during hospitalization between January 2018 and March 2022. Patients were classified into the CMD and non-CMD groups according to the results of MCE. The clinical data and MCE results of both groups were analyzed. Follow-up was conducted for major adverse cardiac events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MCE detected CMD in 105 patients (62.9%). The CMD group contained fewer hypertensive patients (55.2% versus 74.2%, <jats:italic>P<\/jats:italic>\u2009=\u20090.015). Patients with CMD exhibited significantly higher levels of plasma troponin I (TnI) [73.2 (23.0\u2013124.0) versus 28.9 (12.7\u201380.2) ng\/mL, <jats:italic>P<\/jats:italic>\u2009=\u20090.004], higher levels of plasma B-type natriuretic peptide [255 (99\u2013641) versus 193 (59\u2013389) pg\/mL, <jats:italic>P<\/jats:italic>\u2009=\u20090.004], poorer Killip classification (<jats:italic>P<\/jats:italic>\u2009=\u20090.038), and different culprit vessels (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) compared to the non-CMD group. Patients with CMD exhibited lower left ventricular ejection fraction [50 (43\u201358) versus 61 (54\u201367) %, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001], poorer wall motion score index values (1.68\u2009\u00b1\u20090.4 versus 1.31\u2009\u00b1\u20090.26, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and poorer left ventricular global longitudinal strain [\u201311.2 (\u20138.7 to \u201314.1) versus \u201313.9 (\u201311.0 to \u201317.2) %, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001] compared to the non-CMD group. Patients underwent follow-up for 13 (7\u201320) months. After adjusting for hypertension, peak TnI level, culprit vessel, and Killip classification, CMD was an independent predictor of total major adverse cardiac events at 13\u00a0months\u2019 follow-up [adjusted odds ratio (OR), 2.457; 95% confidence interval (CI), 1.042\u20135.790; <jats:italic>P<\/jats:italic>\u2009=\u20090.040], and patients with CMD had a higher risk of hospitalization for heart failure (adjusted OR, 5.184; 95% CI, 1.044\u201325.747; <jats:italic>P<\/jats:italic>\u2009=\u20090.044) and repeat myocardial infarction (adjusted OR, 2.896; 95% CI, 1.109\u20137.565; <jats:italic>P<\/jats:italic>\u2009=\u20090.030).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MCE is a safe and effective method for detecting CMD in patients with STEMI. CMD detected by MCE after successful PCI in patients with STEMI is a common occurrence, which is associated with a significantly worse prognosis, especially hospitalization for heart failure and repeat myocardial infarction.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02947-5","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T08:03:14Z","timestamp":1672214594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Coronary microcirculation dysfunction evaluated by myocardial contrast echocardiography predicts poor prognosis in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention"],"prefix":"10.1186","volume":"22","author":[{"given":"Lan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiangang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"issue":"2","key":"2947_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393.","journal-title":"Eur Heart J"},{"issue":"5","key":"2947_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.5543\/tkda.2020.30020","volume":"48","author":"S Kahraman","year":"2020","unstructured":"Kahraman S, Cam Kahraman F, Zencirkiran Agus H, et al. Perceived stress level is associated with coronary artery disease severity in patients with ST-segment elevation myocardial infarction. Turk Kardiyol Dern Ars. 2020;48(5):494\u2013503. https:\/\/doi.org\/10.5543\/tkda.2020.30020.","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2947_CR3","doi-asserted-by":"publisher","unstructured":"Yildiz I, Renc\u00fczo\u011fullar\u0131 I, Karaba\u011f Y, et al. Predictors of left ventricular ejection function decline in young patients with ST-segment elevation myocardial infarction[J]. Rev Assoc Med Bras (1992), 2022, 68(6): 802\u2013807 https:\/\/doi.org\/10.1590\/1806-9282.20220033.","DOI":"10.1590\/1806-9282.20220033"},{"issue":"4","key":"2947_CR4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/cvr\/cvaa023","volume":"116","author":"PG Camici","year":"2020","unstructured":"Camici PG, Tsch\u00f6pe C, Di Carli MF, et al. Coronary microvascular dysfunction in hypertrophy and heart failure. Cardiovasc Res. 2020;116(4):806\u201316. https:\/\/doi.org\/10.1093\/cvr\/cvaa023.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"2947_CR5","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/ehjci\/jex182","volume":"18","author":"R Senior","year":"2017","unstructured":"Senior R, Becher H, Monaghan M, et al. Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. Eur Heart J Cardiovasc Imaging. 2017;18(11):1205\u20131205. https:\/\/doi.org\/10.1093\/ehjci\/jex182.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"2947_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.15386\/mpr-1261","volume":"92","author":"MC Marc","year":"2019","unstructured":"Marc MC, Iancu AC, B\u0103l\u0103nescu \u015e. Microvascular obstruction in acute myocardial infarction: an old and unsolved mystery. Med Pharm Rep. 2019;92(3):216\u20139. https:\/\/doi.org\/10.15386\/mpr-1261.","journal-title":"Med Pharm Rep"},{"issue":"4","key":"2947_CR7","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/cvr\/cvaa003","volume":"116","author":"T Padro","year":"2020","unstructured":"Padro T, Manfrini O, Bugiardini R, et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on \u2019coronary microvascular dysfunction in cardiovascular disease. Cardiovasc Res. 2020;116(4):741\u201355. https:\/\/doi.org\/10.1093\/cvr\/cvaa003.","journal-title":"Cardiovasc Res"},{"issue":"18","key":"2947_CR8","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). JACC. 2018;72(18):2231\u201364. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1038.","journal-title":"JACC"},{"issue":"1","key":"2947_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"8","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of cardiovascular Imaging. J Am Soc Echocardiogr. 2015;8(1):1-39.e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003.","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"2947_CR10","doi-asserted-by":"publisher","first-page":"e010091","DOI":"10.1161\/CIRCIMAGING.119.010091","volume":"13","author":"F Xie","year":"2020","unstructured":"Xie F, Qian L, Goldsweig A, et al. Event-free survival following successful percutaneous intervention in acute myocardial infarction depends on microvascular perfusion. Circ Cardiovasc Imaging. 2020;13(6):e010091. https:\/\/doi.org\/10.1161\/CIRCIMAGING.119.010091.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"21","key":"2947_CR11","doi-asserted-by":"publisher","first-page":"00050","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"S1071\u20139164","author":"B Bozhurt","year":"2021","unstructured":"Bozhurt B, Coats AJ, Tsutsui H, et al. Universal definition and classification of heart failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021;S1071\u20139164(21):00050\u20136. https:\/\/doi.org\/10.1016\/j.cardfail.2021.01.022.","journal-title":"J Card Fail"},{"issue":"4","key":"2947_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/cvr\/cvz301","volume":"116","author":"LSF Konijnenberg","year":"2020","unstructured":"Konijnenberg LSF, Damman P, Duncker DJ, et al. Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction. Cardiovasc Res. 2020;116(4):787\u2013805. https:\/\/doi.org\/10.1093\/cvr\/cvz301.","journal-title":"Cardiovasc Res"},{"issue":"13","key":"2947_CR13","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/eurheartj\/ehv484","volume":"37","author":"G Niccoli","year":"2016","unstructured":"Niccoli G, Scalone G, Lerman A, et al. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016;37(13):1024\u201333. https:\/\/doi.org\/10.1093\/eurheartj\/ehv484.","journal-title":"Eur Heart J"},{"issue":"5","key":"2947_CR14","doi-asserted-by":"publisher","first-page":"e0268330","DOI":"10.1371\/journal.pone.0268330","volume":"17","author":"M Canu","year":"2022","unstructured":"Canu M, Khouri C, Marliere S, et al. Prognostic significance of severe coronary microvascular dysfunction post-PCI in patients with STEMI: A systematic review and meta-analysis. PLoS ONE. 2022;17(5):e0268330. https:\/\/doi.org\/10.1371\/journal.pone.0268330.","journal-title":"PLoS ONE"},{"issue":"6","key":"2947_CR15","doi-asserted-by":"publisher","first-page":"e12928","DOI":"10.1111\/eci.12928","volume":"48","author":"Y Karaba\u011f","year":"2018","unstructured":"Karaba\u011f Y, \u00c7a\u011fda\u015f M, Rencuzogullari I, et al. Usefulness of The C-Reactive Protein\/Albumin Ratio for Predicting No-Reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur J Clin Invest. 2018;48(6):e12928. https:\/\/doi.org\/10.1111\/eci.12928.","journal-title":"Eur J Clin Invest"},{"key":"2947_CR16","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","volume":"38","author":"S De Waha","year":"2017","unstructured":"De Waha S, Patel MR, Granger CB, et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J. 2017;38:3502\u201310. https:\/\/doi.org\/10.1093\/eurheartj\/ehx414.","journal-title":"Eur Heart J"},{"key":"2947_CR17","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.12659\/MSM.915960","volume":"25","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Fu X, Wang Y, et al. Development and Validation of Risk Nomogram Model Predicting Coronary Microvascular Obstruction in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary Percutaneous Catheterization. Med Sci Monit. 2018;25:5864\u201377. https:\/\/doi.org\/10.12659\/MSM.915960.","journal-title":"Med Sci Monit"},{"issue":"1","key":"2947_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12872-022-02648-z","volume":"22","author":"WY Jin","year":"2022","unstructured":"Jin WY, Wang L, Zhu TG, et al. Usefulness of echocardiographic myocardial work in evaluating the microvascular perfusion in STEMI patients after revascularization. BMC Cardiovasc Disord. 2022;22(1):218. https:\/\/doi.org\/10.1186\/s12872-022-02648-z.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2947_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3969\/j.issn.1004-8812.2022.01.006","volume":"30","author":"W Lan","year":"2022","unstructured":"Lan W, Yuliang M, Weimin W, et al. Coronary microvascular dysfunction predicts impaired cardiac function in acute ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention[J]. Chin J Intervent Cardiol. 2022;30(1):33\u20137. https:\/\/doi.org\/10.3969\/j.issn.1004-8812.2022.01.006.","journal-title":"Chin J Intervent Cardiol"},{"key":"2947_CR20","doi-asserted-by":"publisher","unstructured":"Lan W, Yuliang M, Weimin W, et al. In-hospital major adverse cardiac events in acute myocardial infarction patients with coronary microvascular dysfunction[J].Chin Circulation J, 2021, 36(12): 1170\u20131175 https:\/\/doi.org\/10.3969\/j.issn.1000-3614.2021.12.005.","DOI":"10.3969\/j.issn.1000-3614.2021.12.005"},{"key":"2947_CR21","doi-asserted-by":"publisher","first-page":"e004996","DOI":"10.1161\/CIRCIMAGING.115.004996","volume":"9","author":"A Kali","year":"2016","unstructured":"Kali A, Cokic I, Tang R, et al. Persistent microvascular obstruction after myocardial infarction culminates in the confluence of ferric iron oxide crystals, proinflammatory burden, and adverse remodeling. Circ Cardiovasc Imaging. 2016;9:e004996. https:\/\/doi.org\/10.1161\/CIRCIMAGING.115.004996.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2947_CR22","doi-asserted-by":"publisher","unstructured":"Scarsini R, Shanmuganathan M, De Maria GL, et al. Coronary microvascular dysfunction assessed by pressure wire and CMR after STEMI predicts long-term outcomes [J]. JACC Cardiovasc Imaging, 2021, S1936\u2013878X(21)00205\u20139 https:\/\/doi.org\/10.1016\/j.jcmg.2021.02.023.","DOI":"10.1016\/j.jcmg.2021.02.023"},{"issue":"8","key":"2947_CR23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1161\/CIRCULATIONAHA.118.034309","volume":"138","author":"MS Sabatine","year":"2018","unstructured":"Sabatine MS, De Ferrari GM, Giugliano RP, et al. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER. Circulation. 2018;138(8):756\u201366. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034309.","journal-title":"Circulation"},{"key":"2947_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jacc.2017.11.046","volume":"71","author":"K Ohyama","year":"2018","unstructured":"Ohyama K, Matsumoto Y, Takanami K, et al. Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina. J Am Coll Cardiol. 2018;71:414\u201325. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.046.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2947_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCRESAHA.115.307856","volume":"118","author":"AS Antonopoulos","year":"2016","unstructured":"Antonopoulos AS, Margaritis M, Verheule S, et al. Mutual regulation of epicardial adipose tissue and myocardial redox state by PPAR-c\/adiponectin signaling. Circ Res. 2016;118(5):842\u201355. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307856.","journal-title":"Circ Res"},{"key":"2947_CR26","doi-asserted-by":"publisher","unstructured":"Wo\u00b4jcicka G, Jamroz-Wisniewska A, Atanasova P, et al. Differential effects of statins on endogenous H2S formation in perivascular adipose tissue [J]. Pharmacol Res, 2011, 63: 68\u201376 https:\/\/doi.org\/10.1016\/j.phrs.2010.10.011.","DOI":"10.1016\/j.phrs.2010.10.011"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02947-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02947-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02947-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T08:04:13Z","timestamp":1672214653000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02947-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2947"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02947-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"17 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Peking University People\u2019s Hospital (ethics committee approval number: 2022PHB116-001). Informed consent was provided by all patients. This study conforms with the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"572"}}